PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26326N0316Generic lenalidomide for civahcs — Exelan Pharmaceuticals Inc

Exelan Pharmaceuticals Inc holds $184.3M across 125 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79720D0227. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Network Contract Office 23 (36C263)
Awarding office
Exelan Pharmaceuticals Inc
Recipient
Sep 30, 2026
PoP end
$703K
Obligated
$1.5M
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Exelan Pharmaceuticals Inc — $90

Contract facts

Federal
Contract number36C26326N0316
Also listed as36C263-26-N-0316
Also listed as36F79720D0227-36C26326N0316
AgencyNetwork Contract Office 23 (36C263)
Awarding officeNetwork Contract Office 23 (36C263)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentExelan Pharmaceuticals Inc
CAGE6GFC4
UEIFYZXNHSQTMG8
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0227
Place of performanceBOCA RATON FL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJan 1, 2026
PoP end (current)Sep 30, 2026
Obligated$703K
Current value$703K
Potential value$1.5M

GENERIC LENALIDOMIDE FOR CIVAHCS is a federal award for Network Contract Office 23 (36C263) held by Exelan Pharmaceuticals Inc. Estimated value $1.5M ($703K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: BOCA RATON FL.

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Exelan Pharmaceuticals Inc$184.3M obligated across 125 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($184.3M) · all agencies
Department of Veterans Affairs (VA)$110.2M · 60%Department of Health and Human Services (HHS)$74.1M · 40%Department of Justice (DOJ)$39K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C24826N0088
LENALIDOMIDE
$3.8M
Sep 30, 2026
36C26326F0016
LENOLIDOMIDE CAPSULES
$3.6M
Sep 30, 2026
36C26126N0175
VA PALO ALTO LENALIDOMIDE ORAL CAPSULES
$3.0M
Sep 30, 2026
36C26026F0069
PHARM - LENALIDOMIDE
$1.3M
Sep 30, 2026
36C26326F0019
LENALIDOMIDE CAPSULES
$1.2M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26326N0316?

36C26326N0316 (Generic lenalidomide for civahcs) is a Network Contract Office 23 (36C263) award with a potential value of $1.5M, currently held by Exelan Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C263-26-N-0316?

36C263-26-N-0316 is the dashed form of PIID 36C26326N0316 (Generic lenalidomide for civahcs), held by Exelan Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26326N0316?

Network Contract Office 23 (36C263) awarded 36C26326N0316 to Exelan Pharmaceuticals Inc (potential $1.5M).

Who is the incumbent on 36C26326N0316?

Exelan Pharmaceuticals Inc is the incumbent with $184.3M across 125 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Exelan Pharmaceuticals Inc’s 36C26326N0316 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26326N0316